![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Dexcom’s Glucose Monitoring System Receives FDA Approval
Dexcom’s Glucose Monitoring System Receives FDA Approval
![Grey Approved Stamp](https://www.fdanews.com/ext/resources/test/Drug-Images4/Grey_Approved_Stamp.gif?t=1576541258&width=430)
March 30, 2018
The FDA gave Dexcom’s continuous glucose monitoring system Dexcom G6 marketing approval and classified the product as a Class II device.
The Dexcom G6 can integrate with other medical devices and electronic interfaces like insulin pumps, blood glucose meters and automated insulin dosing systems.
The device is a small patch that users apply to their abdomen. A sensor within the device continuously measures glucose in the user’s body fluid and transmits readings every five minutes to its smartphone app.
Upcoming Events
-
21Oct